(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
There is now a range of cytotoxic drugs that have considerable clinical usefulness in producing responses in tumors and even, in a small proportion of cases, cure. However, the acquisition of drug resistance is a major clinical problem and is perhaps the main limiting factor in successful treatment of cancer. Thus, a tumor initially sensitive to chemotherapy will, in the majority of cases, eventually recur as a resistant tumor, which will then progress. Much of our understanding of drug resistance mechanisms comes from the study of tumor cell lines grown in tissue culture. We now understand many of the - lecular mechanisms that can lead to a cell acquiring resistance to antic- cer drugs; however, we still do not know which mechanism(s) are those most relevant to the problem of clinical drug resistance. Indeed, given that many of the cytotoxic anticancer drugs were discovered by random screening, it is - clear what features give a clinically useful anticancer drug a sufficient the- peutic index to be of value. The aim of Cytotoxic Drug Resistance Mechanisms is to provide pro- cols that are appropriate for examining the mechanisms of cellular resistance to anticancer cytotoxics in human tumor samples. Tumor cell lines have been enormously useful as experimental models of drug resistance mechanisms, however they have limitations and we need to address the relevance of such mechanisms in patients' tumors. Examining drug resistance in tumors is much more problematic than in cell lines.
Contents:
Drug Resistance: The Clinical Perspective
D. Alan Anthoney and Stanley B. Kaye
Cell Sensitivity Assays: Clonogenic Assay
Jane A. Plumb
Cell Sensitivity Assays: The MTT Assay
Jane A. Plumb
Cell Sensitivity Assays: Detection of Apoptotic Cells In Vitro Using the TUNEL Assay
Neil A. Jones and Caroline Dive
Analysis of Apoptosis in Tissue Sections
Vicki Save, Philip J. Coates, and Peter A. Hall
Measurement of P-glycoprotein Function
Henk J. Broxterman
Measuring MDR-1 by Quantitative RT-PCR
Susan E. Bates, Zhirong Zhan, Joanna Regis, and Erick Gamelin
Microtiter Plate Technique for the Measurement of Glutathione in Fresh and Cryopreserved Lymphoblasts Using the Enzyme Recycling Method
Pamela R. Kearns and Andrew G. Hall
Measurement of Reduced Glutathione Using High Pressure Liquid Chromatography
Linda A. Hogarth, Celia M. A. Rabello, and Andrew G. Hall
Topoisomerase I and II Activity Assays
Philippe Pourquier, Glenda Kohlhagen, Li-Ming Ueng, and Yves Pommier
5-Fluorouracil Metabolizing Enzymes
Howard L. McLeod, Lesley H. Milne, and Stephen J. Johnston
Measuring DNA Adducts by Immunoassay (ELISA)
Michael J. Tilby
Measuring Drug-DNA Adducts in Individual Cells
Adrian J. Frank
Measurement of Drug-Induced DNA Interstrand Crosslinking Using the Single Cell Electrophoresis (Comet) Assay
Victoria J. Spanswick, Janet M. Hartley, Timothy H. Ward, and John A. Hartley
PCR Analysis of Microsatellite Instability
Gillian L. Hirst
O 6-Alkylguanine-DNA Alkyltransferase Assay
Amanda J. Watson and Geoffrey P. Margison
Analysis of the p53 Status of Tumors: An Overview of Methods
Jonas Bergh
Bcl-2 Family Immunohistochemistry
Lloyd R. Kelland and Philip J. Beale
Genetic Analysis of Drug Resistance by Fluorescence In Situ Hybridization
W. Nicol Keith
Genetic Analysis of Drug Resistance by ReverseIn Situ Hybridization
W. Nicol Keith
Index
PRODUCT DETAILS
Publisher: Springer (Humana Press Inc.)
Publication date: November, 2010
Pages: 248
Weight: 376g
Availability: Available
Subcategories: Oncology
From the same series
Pottumarthi V Prasad
Michael J. Soares
Mary Kearns-Jonker
Michael J. Soares
John M. S. Bartlett
Guy B. Faguet
Douglas B. Lowrie
Johnson Y. N. Lau
Barbara Driscoll
Stephen M. Palfrey
Alex A. Adjei
Barbara Driscoll
Andrew J. Pollard
Paul Jackson
G. E. Francis
Nagy A. Habib
Marion Leboyer
David J. Perry
Nicholas J. Goulden
Duncan F. Rogers
Hansjorg Hauser
Nair Sreejayan
Jacqueline Boultwood
Brian J. Nickoloff
Donna H. Wang
William R. Skach
Derek Kinchington
John Sinclair
M.Maral Mouradian
P. Elizabeth Rakoczy
Susan A. Brooks
Ronald J.A. Trent
Jerome P. Fennell
Rosalyn D. Blumenthal
Frederic De Ceuninck
Alan Thornhill
Jochen Decker
Erika J. Ernst
Angelo Corti
Andrew P. Cope
Qing Wang
Qing Wang
Jun Zhou
Joseph E. Roulston
Simon J. Read
Frederic De Ceuninck
Margaret H. Baron
Meral Beksac
Andrew Robinson
John Varga
Sabire Ozcan
Tim Illidge
Clare Davy
Emmanuel S. Onaivi
Mark W. Saltzman
William S.M. Wold
W. Scott Champney
William S.M. Wold
Michael S. Goligorsky
Andrew P. Cope
Zhongjie Sun
Rosalyn D. Blumenthal
Ross D. Brown
Daniel J. J. Carr
Thomas O. Joos
Gloria H. Su
Andrew J. Pollard
John R. Stephenson
P. Frederick Sparling
Yvonne A. Barnett
Andrew J.T. George
Tanya Parish
Derek T. O'Hagan
Mark A. Herbert
Ronald L. Nagel
Rob Elles
Margaret Hanausek
C.L. Clayton
Denise L. Doolan
Luisa A. DiPietro
Caroline J. Springer
Harry F. Baker
Stuart H. Ralston
Sukriti Nag
Wieslaw M. Kazmierski
Jonathan M. Rhodes
Udo Schumacher
Hugh A. Tilson
Udo Schumacher
Burkhard Ludewig
Thomas J. Evans
Nigel M. Hooper
Angela F. Drew
Jack H. Mydlo
Katherine Bushby
John Q. Wang
Zhizhong Z. Pan
Steven M. Powell
Kian Fan Chung
Anthony A. Killeen
Andrew H. Baker
James Gray
Luke A.J. O'Neill
Curtis A. Machida
Robert K. Hamatake
Meinir G. Jones
Nair Sreejayan
Meinir G. Jones
W. Scott Champney
Ronald J.A. Trent
Jun Zhou
Hansjorg Hauser
Andrew P. Cope
Andrew P. Cope
Alan R. Thornhill
Meral Beksac
Ann E. Tollefson
Ann E. Tollefson
Qing Wang
Qing Wang
Mark W. Saltzman
Mary Kearns-Jonker